Author:
Sawamura Fusae,Kato Masami,Fujita Kazuhisa,Nakazawa Takahiro,Beardsworth Anthony
Publisher
Japanese Pharmacological Society
Subject
Pharmacology,Molecular Medicine
Reference41 articles.
1. 1 Primary pulmonary hypertension: executive summary from the World Symposium on Primary Pulmonary Hypertension 1998. Rich S, editor. World Health Organization, 6–10 September 1998, Evian, France.
2. 2 Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:40S–47S.
3. 3 Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, et al. Long-term intravenous epoprostenol in primary pulmonary hypertension: Prognostic factors and survival. J Am Coll Cardiol. 2002;40:780–788.
4. 4 Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Robin L, et al. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2003;41:2119–2125.
5. 5 Sitbon O, Gressin V, Speich R, Macdonald PS, Opravil M, Cooper DA, et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2004;170:1212–1217.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献